EAM Investors’s Evolus EOLS Stock Holding History

EAM Investors’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-405,341	Closed	-$4.7M	–	280
2022 Q2	$4.7M	Buy	405,341 +102,752	+34%	+$1.21M	1.15%	5
2022 Q1	$3.4M	Buy	+302,589	New	+$2.58M	0.63%	29
2019 Q2	–	Sell	-88,615	Closed	-$2M	–	271
2019 Q1	$2M	Buy	+88,615	New	+$1.92M	0.49%	65

Other funds holding EOLS

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors's EOLS Position: Q3 2022 in Review

EAM Investors sold out of Evolus (EOLS) in Q3 2022, closing a stake of 405,341 shares — an estimated $4.7M sold.

EAM Investors first reported a position in EOLS in Q1 2019 and held it in 3 quarters. The position peaked at $4.7M in Q2 2022. 130 funds tracked by Wall St. Rank hold EOLS as of Q3 2022.

EAM Investors reported no remaining Evolus position as of Q3 2022 after selling out during the quarter.
EAM Investors sold 405,341 Evolus shares in Q3 2022, an estimated $4.7M.
EAM Investors first reported a position in Evolus in Q1 2019 and held it in 3 quarters.
EAM Investors's Evolus position peaked at $4.7M in Q2 2022.
130 funds tracked by Wall St. Rank held Evolus as of Q3 2022.

Based on EAM Investors's 13F filing for Q3 2022, filed 14 Nov 2022.